Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19

NCT04646655 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
142
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

ASST Fatebenefratelli Sacco

Collaborators